A Phase 2 Study of Aflibercept for the Treatment of Relapsed or Refractory Multiple Myeloma
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2015
At a glance
- Drugs Aflibercept (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 02 May 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 22 Mar 2007 New trial record.